Johnson & Johnson (NYSE: JNJ) today announced first results from Cohort 4 of the Phase 2b SunRISe-1 study evaluating TAR-200—an intravesical gemcitabine releasing system—for patients with certain types of bladder cancer. These first results show the promise of TAR-200 in this patient population with more than an 80 percent disease-free survival (DFS) rate without the need for reinduction and 94 percent of patients able to preserve their bladder. The high DFS and bladder preservation rate combine
Johnson & Johnson (NYSE: JNJ) today announced new data from Cohort 2 of the pivotal Phase 2b SunRISe-1 study evaluating TAR-200—an intravesical gemcitabine releasing system—for patients with certain types of bladder cancer. The findings demonstrate the highest complete response rate without reinduction with more than half of responders remaining cancer-free for at least 12 months. These results highlight the potential of TAR-200 as a breakthrough for people with Bacillus Calmette-Guérin (BCG)-un
McDonald's (NYSE:MCD) recently enhanced its lobbying-related disclosures following shareholder feedback, reinforcing its commitment to investor engagement. A 10% price increase in the last quarter aligns closely with the market's upward momentum. During this period, the announcement of a new share repurchase program contributed additional weight to McDonald's positive performance, providing reassurance amid broader market trends. Although the company reported lower Q4 earnings compared to the...
“Now Streaming” is The Fly’s weekly recap of the stories surrounding the biggest content streamers. PLAYING THIS WEEKEND: Among this weekend’s highly-anticipated new streaming content is the first few episodes of “Andor,” a drama series set in the “Star Wars” universe, on Disney+ (DIS). Meanwhile, Netflix (NFLX) subscribers can catch the fifth season of drama series “You,” as well as neo-noir action thriller film “Havoc,” starring Tom Hardy and Forest Whitaker. Additionally, Amazon Prime Video (
Despite the latest turmoil that's rattling the market due to concerns about how President Donald Trump's trade policies will play out, the S&P 500 index has done a good job compounding investor capital over the long run. In the past 10 years, the widely followed benchmark has produced a total return, including dividends, of 194%. Had you invested in the Invesco QQQ Trust (NASDAQ: QQQ) in April 2015, you would have registered a spectacular total return of 333%.
OK